Hao Jiang, based in Denmark, is currently a Director, Emerging Technologies API MSAT (Synthetic Platforms and Chemical Entities) at Novo Nordisk. Hao Jiang brings experience from previous roles at Novo Nordisk, AGC Biologics and Lundbeck. Hao Jiang holds a 2007 - 2011 Doctor of Philosophy (Ph.D.) in Organic Chemistry @ Aarhus Universitet. Hao Jiang has 1 emails on RocketReach.
Looking for a different Hao Jiang?
Find contact details for 700 million professionals.